AYTU BIOPHARMA, INC Share-based Payment Arrangement, Expense
AYTU BIOPHARMA, INC (AYTU) reported Share-based Payment Arrangement, Expense of $691.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-09-22
- AYTU BIOPHARMA, INC share-based payment arrangement, expense for the quarter ending 2026-06-30 was $146.00K, a 29.20% increase year-over-year.
- AYTU BIOPHARMA, INC share-based payment arrangement, expense for the quarter ending 2026-03-31 was $148.00K, a 6.47% increase year-over-year.
- AYTU BIOPHARMA, INC share-based payment arrangement, expense for the quarter ending 2025-12-31 was $283.00K, a 87.42% increase year-over-year.
- AYTU BIOPHARMA, INC share-based payment arrangement, expense for the quarter ending 2025-09-30 was $114.00K, a 34.10% decline year-over-year.
- AYTU BIOPHARMA, INC share-based payment arrangement, expense for fiscal 2026 was $691.00K, a 19.97% increase from fiscal 2025.
- AYTU BIOPHARMA, INC share-based payment arrangement, expense for fiscal 2025 was $576.00K, a 80.23% decline from fiscal 2024.
- AYTU BIOPHARMA, INC share-based payment arrangement, expense for fiscal 2024 was $2.91M, a 51.82% decline from fiscal 2023.
- AYTU BIOPHARMA, INC share-based payment arrangement, expense for fiscal 2023 was $6.05M, a 15.21% increase from fiscal 2022.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $294.00K derived: sum of 2 quarters · filed 2026-09-22 | $577.00K derived: sum of 3 quarters · filed 2026-09-22 | $691.00K 10-K · filed 2026-09-22 | ||
| 2026-03-31 | $148.00K 10-Q · filed 2026-05-13 | $431.00K derived: sum of 2 quarters · filed 2026-05-13 | $545.00K 10-Q · filed 2026-05-13 | $658.00K derived: sum of 4 quarters · filed 2026-09-22 | ||
| 2025-12-31 | $283.00K 10-Q · filed 2026-02-03 | $397.00K 10-Q · filed 2026-02-03 | $510.00K derived: sum of 3 quarters · filed 2026-09-22 | $649.00K derived: sum of 4 quarters · filed 2026-09-22 | ||
| 2025-09-30 | $114.00K 10-Q · filed 2025-11-13 | $227.00K derived: sum of 2 quarters · filed 2026-09-22 | $366.00K derived: sum of 3 quarters · filed 2026-09-22 | $517.00K derived: sum of 4 quarters · filed 2026-09-22 | ||
| 2025-06-30 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $252.00K derived: sum of 2 quarters · filed 2026-09-22 | $403.00K derived: sum of 3 quarters · filed 2026-09-22 | $576.00K 10-K · filed 2026-09-22 | ||
| 2025-03-31 | $139.00K 10-Q · filed 2026-05-13 | $290.00K derived: sum of 2 quarters · filed 2026-05-13 | $463.00K 10-Q · filed 2026-05-13 | $815.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $151.00K 10-Q · filed 2026-02-03 | $324.00K 10-Q · filed 2026-02-03 | $676.00K derived: sum of 3 quarters · filed 2026-02-03 | $1.49M derived: sum of 4 quarters · filed 2026-02-03 | ||
| 2024-09-30 | $173.00K 10-Q · filed 2025-11-13 | $525.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.34M derived: sum of 3 quarters · filed 2025-11-13 | $2.16M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $1.16M derived: sum of 2 quarters · filed 2025-09-23 | $1.98M derived: sum of 3 quarters · filed 2025-09-23 | $2.91M 10-K · filed 2025-09-23 | ||
| 2024-03-31 | $811.00K 10-Q · filed 2025-05-14 | $1.63M derived: sum of 2 quarters · filed 2025-05-14 | $2.56M 10-Q · filed 2025-05-14 | $3.46M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $820.00K 10-Q · filed 2025-02-12 | $1.75M 10-Q · filed 2025-02-12 | $2.65M derived: sum of 3 quarters · filed 2025-02-12 | $3.55M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-09-30 | $930.00K 10-Q · filed 2024-11-13 | $1.83M derived: sum of 2 quarters · filed 2024-11-13 | $2.73M derived: sum of 3 quarters · filed 2024-11-13 | $5.80M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $1.80M derived: sum of 2 quarters · filed 2024-09-26 | $4.87M derived: sum of 3 quarters · filed 2024-09-26 | $6.05M 10-K · filed 2024-09-26 | ||
| 2023-03-31 | $902.00K 10-Q · filed 2024-05-15 | $3.97M derived: sum of 2 quarters · filed 2024-05-15 | $5.15M 10-Q · filed 2024-05-15 | $6.38M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $3.07M 10-Q · filed 2024-02-14 | $4.24M 10-Q · filed 2024-02-14 | $5.47M derived: sum of 3 quarters · filed 2024-02-14 | $6.74M derived: sum of 4 quarters · filed 2024-02-14 | ||
| 2022-09-30 | $1.18M 10-Q · filed 2023-11-14 | $2.41M derived: sum of 2 quarters · filed 2023-11-14 | $3.68M derived: sum of 3 quarters · filed 2023-11-14 | $4.91M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $2.50M derived: sum of 2 quarters · filed 2023-10-12 | $3.73M derived: sum of 3 quarters · filed 2023-10-12 | $5.25M 10-K · filed 2023-10-12 | ||
| 2022-03-31 | $1.27M 10-Q · filed 2023-05-11 | $2.50M derived: sum of 2 quarters · filed 2023-05-11 | $4.02M 10-Q · filed 2023-05-11 | $5.11M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $1.23M 10-Q · filed 2023-02-21 | $2.75M 10-Q · filed 2023-02-21 | $3.84M derived: sum of 3 quarters · filed 2023-02-21 | $5.36M derived: sum of 4 quarters · filed 2023-02-21 | ||
| 2021-09-30 | $1.52M 10-Q/A · filed 2023-02-21 | $2.61M derived: sum of 2 quarters · filed 2023-02-21 | $4.13M derived: sum of 3 quarters · filed 2023-02-21 | $4.64M derived: sum of 4 quarters · filed 2023-02-21 | ||
| 2021-06-30 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $2.61M derived: sum of 2 quarters · filed 2022-09-27 | $3.12M derived: sum of 3 quarters · filed 2022-09-27 | $3.57M 10-K · filed 2022-09-27 | ||
| 2021-03-31 | $1.52M 10-Q · filed 2022-05-16 | $1.53M 10-Q · filed 2021-05-17 | $2.03M derived: sum of 2 quarters · filed 2022-05-16 | $2.48M 10-Q · filed 2022-05-16 | $2.97M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $508.00K 10-Q · filed 2022-02-14 | $963.00K 10-Q · filed 2022-02-14 | $1.45M derived: sum of 3 quarters · filed 2022-02-14 | $1.72M derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2020-09-30 | $455.00K 10-Q · filed 2021-11-15 | $943.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.21M derived: sum of 3 quarters · filed 2021-11-15 | $1.37M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $752.00K derived: sum of 2 quarters · filed 2021-09-28 | $914.00K derived: sum of 3 quarters · filed 2021-09-28 | $1.08M 10-K · filed 2021-09-28 | ||
| 2020-03-31 | $264.00K 10-Q · filed 2021-05-17 | $426.00K derived: sum of 2 quarters · filed 2021-05-17 | $591.00K 10-Q · filed 2021-05-17 | $890.00K derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $162.00K 10-Q · filed 2020-02-14 | $327.00K 10-Q · filed 2020-02-14 | $626.00K derived: sum of 3 quarters · filed 2020-11-12 | $1.00M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-09-30 | $165.00K 10-Q · filed 2020-11-12 | $464.00K derived: sum of 2 quarters · filed 2020-11-12 | $841.00K derived: sum of 3 quarters · filed 2020-11-12 | $1.03M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-06 | $676.00K derived: sum of 2 quarters · filed 2020-10-06 | $870.00K derived: sum of 3 quarters · filed 2020-10-06 | $1.02M 10-K · filed 2020-10-06 | ||
| 2019-03-31 | $377.00K 10-Q · filed 2020-05-15 | $571.00K derived: sum of 2 quarters · filed 2020-05-15 | $723.00K 10-Q · filed 2020-05-15 | $873.00K derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-12-31 | $194.00K 10-Q · filed 2020-02-14 | $346.00K 10-Q · filed 2020-02-14 | $496.00K derived: sum of 3 quarters · filed 2020-02-14 | $563.00K derived: sum of 4 quarters · filed 2020-02-14 | ||
| 2018-09-30 | $152.00K 10-Q · filed 2019-11-14 | $302.00K derived: sum of 2 quarters · filed 2019-11-14 | $369.00K derived: sum of 3 quarters · filed 2019-11-14 | $482.00K derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $217.00K derived: sum of 2 quarters · filed 2019-09-26 | $330.00K derived: sum of 3 quarters · filed 2019-09-26 | $597.00K 10-K · filed 2019-09-26 | ||
| 2018-03-31 | $67.00K 10-Q · filed 2019-05-14 | $180.00K derived: sum of 2 quarters · filed 2019-05-14 | $447.00K 10-Q · filed 2019-05-14 | $776.00K derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $113.00K 10-Q · filed 2019-05-14 | $380.00K 10-Q · filed 2019-05-14 | $709.00K derived: sum of 3 quarters · filed 2019-05-14 | $2.02M derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-09-30 | $267.00K 10-Q · filed 2018-11-07 | $596.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.91M derived: sum of 3 quarters · filed 2018-11-07 | $2.38M derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | $329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | $1.65M derived: sum of 2 quarters · filed 2018-09-06 | $2.11M derived: sum of 3 quarters · filed 2018-09-06 | $3.23M 10-K · filed 2018-09-06 | $2.50M 10-K · filed 2017-08-31 | |
| 2017-03-31 | $1.32M 10-Q · filed 2018-05-14 | $1.78M derived: sum of 2 quarters · filed 2018-05-14 | $2.90M 10-Q · filed 2018-05-14 | |||
| 2016-12-31 | $463.00K 10-Q · filed 2018-02-08 | $1.58M 10-Q · filed 2018-02-08 | ||||
| 2016-09-30 | $1.12M 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | $903.00K 10-K · filed 2017-08-31 | |||||
| 2015-12-31 | $183.00K 10-Q · filed 2016-02-11 | $251.00K 10-Q · filed 2016-02-11 | $519.00K derived: sum of 3 quarters · filed 2016-02-11 | $791.00K derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2015-09-30 | $68.00K 10-Q · filed 2015-11-06 | $336.00K derived: sum of 2 quarters · filed 2015-11-06 | $608.00K derived: sum of 3 quarters · filed 2015-11-06 | $884.00K derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2015-06-30 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $540.00K derived: sum of 2 quarters · filed 2015-09-28 | $816.00K derived: sum of 3 quarters · filed 2016-02-11 | $1.02M 10-K · filed 2015-09-28 | ||
| 2015-03-31 | $272.00K 10-Q · filed 2015-05-19 | $548.00K derived: sum of 2 quarters · filed 2016-02-11 | $750.00K 10-Q · filed 2015-05-19 | $865.00K derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-12-31 | $276.00K 10-Q · filed 2016-02-11 | $478.00K 10-Q · filed 2016-02-11 | $593.00K derived: sum of 3 quarters · filed 2016-02-11 | $677.00K derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-09-30 | $202.00K 10-Q · filed 2015-11-06 | $317.00K derived: sum of 2 quarters · filed 2015-11-06 | $401.00K derived: sum of 3 quarters · filed 2015-11-06 | |||
| 2014-06-30 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $199.00K derived: sum of 2 quarters · filed 2015-09-28 | $500.00K 10-K · filed 2015-09-28 | |||
| 2014-03-31 | $84.00K 10-Q · filed 2015-05-19 | $385.00K 10-Q · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |